iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
73 hedge funds and large institutions have $422M invested in iKang Healthcare Group, Inc. in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 15 closing their positions.
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
9% more funds holding
Funds holding: 67 → 73 (+6)
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
25% less capital invested
Capital invested by funds: $564M → $422M (-$142M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
67% less call options, than puts
Call options by funds: $1.62M | Put options by funds: $4.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$31.3M |
| 2 |
QF
QVT Financial
New York
|
+$20.1M |
| 3 |
First Manhattan
New York
|
+$12.6M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$12.5M |
| 5 |
Renaissance Technologies
New York
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$94.9M |
| 2 |
Goldman Sachs
New York
|
-$71.1M |
| 3 |
SC
Sculptor Capital
New York
|
-$54.1M |
| 4 |
SIM
Summitview Investment Management
Grand Cayman,
Cayman Islands
|
-$18.7M |
| 5 |
JP Morgan Chase
New York
|
-$17.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Barclays
London,
United Kingdom
| – | -$3.9M | -194,854 | Closed |
|
|
AGA
77
Altrinsic Global Advisors
Stamford,
Connecticut
| – | -$3.06M | -149,747 | Closed |
|
78
Mirae Asset Global Investments
Seoul,
South Korea
| – | -$2.54M | -124,100 | Closed |
|
79
Arrowstreet Capital
Boston,
Massachusetts
| – | -$1.96M | -95,875 | Closed |
|
|
GF
80
Gabelli Funds
Rye,
New York
| – | -$1.33M | -65,000 | Closed |
|
|
ACP
81
Ashfield Capital Partners
San Francisco,
California
| – | -$1.27M | -62,236 | Closed |
|
82
D.E. Shaw & Co
New York
| – | -$639K | -31,284 | Closed |
|
|
TAA
83
TB Alternative Assets
Grand Cayman,
Cayman Islands
| – | -$626K | -30,649 | Closed |
|
|
PAM
84
Prudence Asset Management
Hong Kong
| – | -$582K | -28,453 | Closed |
|
|
CS
85
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| – | -$286K | -14,000 | Closed |
|
|
GI
86
GAMCO Investors
Greenwich,
Connecticut
| – | -$205K | -10,007 | Closed |
|
|
CM
87
Castleark Management
Chicago,
Illinois
| – | -$180K | -8,810 | Closed |
|
88
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$72.5K | -3,479 | -100% |
|
KANG Hedge Fund Activity: Q1 2016 in Review
73 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q1 2016, worth a combined $422M — down 25% from $564M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new KANG positions and 15 closed out — a net gain of 6 holders — while 23 added to existing stakes and 25 trimmed.
The largest buyer was Pine River Capital Management, adding an estimated $31.3M. The largest seller was Wellington Management Group, cutting an estimated $94.9M.
- 73 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q1 2016, up from 67 in Q4 2015.
- Funds reported $422M of iKang Healthcare Group, Inc. stock for Q1 2016, down 25% quarter-over-quarter.
- 21 funds opened new iKang Healthcare Group, Inc. positions in Q1 2016 and 15 closed out, a net change of +6 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q1 2016 was Pine River Capital Management, an estimated $31.3M added.
- The largest iKang Healthcare Group, Inc. seller in Q1 2016 was Wellington Management Group, an estimated $94.9M sold.
Based on aggregated 13F filings for Q1 2016.